skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 617  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing
Material Type:
Article
Add to My Research

Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing

Cancer science, 2022-01, Vol.113 (1), p.308-318 [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15181 ;PMID: 34710947

Full text available

2
Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial
Material Type:
Article
Add to My Research

Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial

Cancer science, 2018-06, Vol.109 (6), p.1930-1938 [Peer Reviewed Journal]

2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13623 ;PMID: 29697876

Full text available

3
Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients
Material Type:
Article
Add to My Research

Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients

Japanese journal of clinical oncology, 2018-07, Vol.48 (7), p.609-618 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy069 ;PMID: 29767751

Full text available

4
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study
Material Type:
Article
Add to My Research

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study

Japanese journal of clinical oncology, 2018-11, Vol.48 (11), p.1012-1021 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy129 ;PMID: 30371895

Full text available

5
A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC
Material Type:
Article
Add to My Research

A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC

Japanese journal of clinical oncology, 2018-12, Vol.48 (12), p.1088-1095 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy136 ;PMID: 30257010

Full text available

6
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset
Material Type:
Article
Add to My Research

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.367-375 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy016 ;PMID: 29474558

Full text available

7
Relation Between Identity Disclosure to Family Members and Mental Health in Japanese Transgender People
Material Type:
Article
Add to My Research

Relation Between Identity Disclosure to Family Members and Mental Health in Japanese Transgender People

Acta medica Okayama, 2021-10, Vol.75 (5), p.611-623 [Peer Reviewed Journal]

ISSN: 0386-300X ;DOI: 10.18926/amo/62774 ;PMID: 34703044

Full text available

8
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class
Material Type:
Article
Add to My Research

A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.317-321 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy010 ;PMID: 29474553

Full text available

9
NR3C1 gene polymorphisms are associated with high-altitude pulmonary edema in Han Chinese
Material Type:
Article
Add to My Research

NR3C1 gene polymorphisms are associated with high-altitude pulmonary edema in Han Chinese

Journal of physiological anthropology, 2019-04, Vol.38 (1), p.4-4, Article 4 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1880-6805 ;ISSN: 1880-6791 ;EISSN: 1880-6805 ;DOI: 10.1186/s40101-019-0194-1 ;PMID: 30999951

Full text available

10
Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients
Material Type:
Article
Add to My Research

Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients

Japanese journal of clinical oncology, 2017-12, Vol.47 (12), p.1182-1188 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx139 ;PMID: 29036563

Full text available

11
Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples
Material Type:
Article
Add to My Research

Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples

Cancer science, 2018-04, Vol.109 (4), p.1177-1184 [Peer Reviewed Journal]

2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13511 ;PMID: 29363250

Full text available

12
Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population
Material Type:
Article
Add to My Research

Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population

Japanese journal of clinical oncology, 2018-08, Vol.48 (8), p.728-735 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy081 ;PMID: 29889250

Full text available

13
First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial
Material Type:
Article
Add to My Research

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial

Japanese journal of clinical oncology, 2017-05, Vol.47 (5), p.385-392 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx001 ;PMID: 28158579

Full text available

14
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset
Material Type:
Article
Add to My Research

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset

Japanese journal of clinical oncology, 2017-07, Vol.47 (7), p.618-624 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx045 ;PMID: 28369553

Full text available

15
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors
Material Type:
Article
Add to My Research

Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.322-328 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy026 ;PMID: 29514256

Full text available

16
Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13
Material Type:
Article
Add to My Research

Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.329-334 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy022 ;PMID: 29506049

Full text available

17
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia
Material Type:
Article
Add to My Research

Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia

Japanese journal of clinical oncology, 2017-01, Vol.47 (1), p.54-60 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw146 ;PMID: 28122892

Full text available

18
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial
Material Type:
Article
Add to My Research

Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

Japanese journal of clinical oncology, 2017-06, Vol.47 (6), p.551-559 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. ;The Author 2017. Published by Oxford University Press. 2017 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw194 ;PMID: 28334974

Full text available

19
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
Material Type:
Article
Add to My Research

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma

Cancer science, 2021-01, Vol.112 (1), p.305-313 [Peer Reviewed Journal]

2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14681 ;PMID: 33047430

Full text available

20
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study
Material Type:
Article
Add to My Research

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

Cancer science, 2020-02, Vol.111 (2), p.513-527 [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14264 ;PMID: 31789476

Full text available

Results 1 - 20 of 617  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (600)

Refine My Results

Creation Date 

From To
  1. Before 1995  (11)
  2. 1995 To 2003  (16)
  3. 2004 To 2010  (157)
  4. 2011 To 2018  (388)
  5. After 2018  (46)
  6. More options open sub menu

Searching Remote Databases, Please Wait